Impact of biochemical failure on long-term clinical outcome after radical prostatectomy for prostate cancer in Japan

被引:7
作者
Egawa, S
Matsui, Y
Matsumoto, K
Suyama, K
Arai, Y
Kuwao, S
Baba, S
机构
[1] Kitasato Univ, Sch Med, Dept Urol, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Med, Dept Pathol, Kanagawa 2288555, Japan
[3] Kurashiki Cent Hosp, Dept Urol, Okayama, Japan
关键词
radical prostatectomy; prostate-specific antigen; biochemical failure; overall survival;
D O I
10.1038/sj.pcan.4500715
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Detailed information is needed to understand the impact of biochemical failure (bF) on long-term outcome after definitive therapy for prostate cancer. In all, 223 consecutive men treated with radical retropubic prostatectomy were followed and long-term clinical outcome was investigated. Pathological examination revealed more locally advanced tumors in this study compared with the typical cohorts seen in the Western series. The Cox proportional hazards model indicates pretreatment prostate-specific antigen levels and risk group stratification to be a significant predictors for bF (P<0.05), but not for overall survival. Seminal vesicle involvement was a significant predictor of systemic progression, cancer death and overall survival (P<0.05). Positive surgical margin and bF were also found to be independent predictors of overall survival (P<0.05). In contrast to reports from Western countries, this study found a significant correlation between bF after radical prostatectomy and overall survival. This may reflect years-later detection of prostate cancer in Japan compared with Western series. Biochemical failure may ultimately be translated into decreased overall survival after sufficient follow-up.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 19 条
  • [1] [Anonymous], GEN RUL CLIN PATH ST
  • [2] [Anonymous], TNM CLASSIFICATION M
  • [3] Radical prostatectomy nomograms in black American men: Accuracy and applicability
    Bianco, FJ
    Kattan, MW
    Scardino, PT
    Powell, IJ
    Pontes, JE
    Wood, DP
    [J]. JOURNAL OF UROLOGY, 2003, 170 (01) : 73 - 76
  • [4] Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results
    Catalona, WJ
    Smith, DS
    [J]. JOURNAL OF UROLOGY, 1998, 160 (06) : 2428 - 2434
  • [5] Pretreatment predictors of time to cancer specific death after prostate specific antigen failure
    D'Amico, AV
    Cote, K
    Loffredo, M
    Renshaw, AA
    Chen, MH
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04) : 1320 - 1324
  • [6] Egawa S, 1999, CANCER, V86, P463
  • [7] Infrequent involvement of the anterior base in low-risk patients with clinically localized prostate cancer and its possible significance in definitive radiation therapy
    Egawa, S
    Takashima, R
    Matsumoto, K
    Mizoguchi, H
    Kuwao, S
    Baba, S
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (03) : 126 - 130
  • [8] Impact of life expectancy and tumor doubling time on the clinical significance of prostate cancer in Japan
    Egawa, S
    Matsumoto, K
    Iwamura, M
    Uchida, T
    Kuwao, S
    Koshiba, K
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (06) : 394 - 400
  • [9] Detection of prostate cancer by prostate-specific antigen
    Egawa, S
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (03) : 130 - 134
  • [10] Gerber GS, 1996, JAMA-J AM MED ASSOC, V276, P615